Literature DB >> 33610690

Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries.

Koon K Teo1, Talha Rafiq2.   

Abstract

By the beginning of the 21st century, cardiovascular disease (CVD) had become the leading cause of premature mortality and morbidity worldwide, with 80% originating from less developed lower-income countries in line with societal and economic developments. Extensive research on causes and risk factors have been carried out since the mid-20th century and have established individual factors such as smoking, hypertension, diabetes, and dyslipidemia as CVD risk factors, followed by others. Two recent major case-control studies have summarized the role of common major CVD risk factors in determining the risk of myocardial infarction (INTERHEART study) and stroke (INTERSTROKE study). They showed that 9 and 10 common risk factors accounted for > 90% of the risk of myocardial infarction and stroke, respectively, and established the focus in prevention of these common CVDs. The efficacy of lowering blood pressure, blood glucose, and lipid-lowering therapies has been shown to reduce subsequent morbidity and mortality. Leading international health organizations have published guidelines that are updated regularly to set the standards for providing guidance for implementation and management of risk factors. Interventions can also be costly and long-term adherence, essential to be effective in reducing risks, tends to decrease drastically with time. Dietary recommendations have been incorporated into national and professional guidelines for CVD prevention since the 1960s. On the basis of new research, some existing dietary recommendation might be outdated and should be reviewed, and revised, if necessary. A perspective of CVD prevention and treatment in developing countries is highlighted.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33610690     DOI: 10.1016/j.cjca.2021.02.009

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  11 in total

1.  Evaluation of the serum levels of Mannose binding lectin-2, tenascin-C, and total antioxidant capacity in patients with coronary artery disease.

Authors:  Hamed Mehri; Naser Aslanabadi; Alireza Nourazarian; Behrouz Shademan; Fatemeh Khaki-Khatibi
Journal:  J Clin Lab Anal       Date:  2021-09-07       Impact factor: 2.352

2.  Clinical Evaluation of a Novel Tablet Formulation of Traditional Thai Polyherbal Medicine Named Nawametho in Comparison with Its Decoction in the Treatment of Hyperlipidemia.

Authors:  Patcharawalai Jaisamut; Channong Tohlang; Subhaphorn Wanna; Acharaporn Thanakun; Thawatchai Srisuwan; Surasak Limsuwan; Wissava Rattanachai; Jarinee Suwannachot; Sasitorn Chusri
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

3.  Association of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study.

Authors:  Gilberto Vargas-Alarcón; Maria Del Carmen González-Salazar; Adrian Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Julian Ramírez-Bello; José Manuel Rodríguez-Pérez; Rosalinda Posadas-Sánchez
Journal:  Diagnostics (Basel)       Date:  2022-07-15

4.  A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al18F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease.

Authors:  Zhehao Lyu; Wei Han; Hongyue Zhao; Yuying Jiao; Peng Xu; Yangyang Wang; Qiuyi Shen; Shuai Yang; Changjiu Zhao; Lin Tian; Peng Fu
Journal:  Front Cardiovasc Med       Date:  2022-08-22

Review 5.  DPP4 as a Potential Candidate in Cardiovascular Disease.

Authors:  Si-Yu Chen; Xiang-Quan Kong; Ke-Fan Zhang; Shuai Luo; Feng Wang; Jun-Jie Zhang
Journal:  J Inflamm Res       Date:  2022-09-16

6.  Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.

Authors:  Yuanyuan Li; Zhongyan Wang
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

7.  Association of rs1137101 with hypertension and type 2 diabetes mellitus of Mongolian and Han Chinese.

Authors:  Ke-Yu Zhao; Meng-Lu Yuan; Yun-Na Wu; Hong-Wei Cui; Wen-Yan Han; Jing Wang; Xiu-Lan Su
Journal:  World J Diabetes       Date:  2022-08-15

8.  Association of healthy lifestyles on the risk of hypertension, type 2 diabetes mellitus, and their comorbidity among subjects with dyslipidemia.

Authors:  Peng Hu; Murui Zheng; Xueru Duan; Huanning Zhou; Jun Huang; Lixian Lao; Yue Zhao; Yi Li; Meng Xue; Wenjing Zhao; Hai Deng; Xudong Liu
Journal:  Front Nutr       Date:  2022-09-26

9.  In Situ Maturated Early-Stage Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improve Cardiac Function by Enhancing Segmental Contraction in Infarcted Rats.

Authors:  Diogo Biagi; Evelyn Thais Fantozzi; Julliana Carvalho Campos-Oliveira; Marcus Vinicius Naghetini; Antonio Fernando Ribeiro; Sirlene Rodrigues; Isabella Ogusuku; Rubia Vanderlinde; Michelle Lopes Araújo Christie; Debora Bastos Mello; Antonio Carlos Campos de Carvalho; Marcos Valadares; Estela Cruvinel; Rafael Dariolli
Journal:  J Pers Med       Date:  2021-05-04

10.  APOE gene ɛ4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population.

Authors:  Qinghua Liu; Heming Wu; Zhikang Yu; Qingyan Huang; Zhixiong Zhong
Journal:  J Clin Lab Anal       Date:  2021-07-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.